We report a case of possible congenital tuberculosis in a 22+2 weeks, 460 g, vaginally delivered female infant born to a mother suffering from tuberculous endometritis, diagnosed soon after delivery. At 156 days of age, Mycobacterium tuberculosis was detected via PCR from the infant's gastric juice and was subsequently isolated. There was no evidence for horizontal transmission. Mother and child were treated successfully. This case illustrates the possibility of significant latency between infection and clinical manifestation in preterm infants and also emphasizes the need for urgent treatment of neonates in such situations.

Keywords:
Extremely low birth weight, Congenital tuberculosis, Mycobacteria, Preterm infant, Neonate
1.
Hageman J, Shulman S, Schreiber M, Luck S, Yogev R: Congenital tuberculosis: critical reappraisal of clinical findings and diagnostic procedures. Pediatrics 1980;66:980-984.
2.
Asuquo B, Vellore AD, Walters G, Manney S, Mignini L, Kunst H: A case-control study of the risk of adverse perinatal outcomes due to tuberculosis during pregnancy. J Obstet Gynaecol 2012;32:635-638.
3.
Nhan-Chang C-L, Jones TB: Tuberculosis in pregnancy. Clin Obstet Gynecol 2010;53:311-321.
4.
Mathad JS, Gupta A: Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gaps. Clin Infect Dis 2012;55:1532-1549.
5.
Beitzke H: Über die angeborene tuberkulöse Infektion. Ergeb Gesamten Tuberkuloseforsch 1935;7.
6.
Cantwell MF, Shehab ZM, Costello AM, Sands L, Green WF, Ewing EP, et al: Brief report: congenital tuberculosis. N Engl J Med 1994;330:1051-1054.
7.
Peng W, Yang J, Liu E: Analysis of 170 cases of congenital TB reported in the literature between 1946 and 2009. Pediatr Pulmonol 2011;46:1215-1224.
8.
Gray DM, Zar H, Cotton M: Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children. Cochrane Database Syst Rev 2009;1: CD006418.
9.
Grenville-Mathers R, Harris WC, Trenchard HJ: Tuberculous primary infection in pregnancy and its relation to congenital tuberculosis. Tubercle 1960;41:181-185.
10.
Tripathy SN: Laparoscopic observations of pelvic organs in pulmonary tuberculosis. Int J Gynaecol Obstet 1990;32:129-131.
11.
Pillay T, Khan M, Moodley J, Adhikari M, Coovadia H: Perinatal tuberculosis and HIV-1: considerations for resource-limited settings. Lancet Infect Dis 2004;4:155-165.
12.
Graham SM: Treatment of paediatric TB: revised WHO guidelines. Paediatr Respir Rev 2011;12:22-26.
13.
Le Doare K, Barber N, Doerholt K, Sharland M: Rifampicin pharmacokinetics in extreme prematurity to treat congenital tuberculosis. BMJ Case Rep 2013, DOI: 10.1136/bcr-2012-008207.
14.
Whittaker E, Kampmann B: Perinatal tuberculosis: new challenges in the diagnosis and treatment of tuberculosis in infants and the newborn. Early Hum Dev 2008;84:795-799.
15.
Kabra SK, Jain Y, Madhulika, Bagga A: Congenital tuberculosis. N Engl J Med 1994;331:548-549.
16.
Schaaf HS, Collins A, Bekker A, Davies PDO: Tuberculosis at extremes of age. Respirology 2010;15:747-763.
17.
Abramowsky CR, Gutman J, Hilinski JA: Mycobacterium tuberculosis Infection of the placenta: a study of the early (innate) inflammatory response in two cases. Pediatr Dev Pathol 2012;15:132-136.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.